| 首 页|| 电生理知识|| 电生理设备|| 电生理导管|| 行业新闻|| 行业网站|| 在线留言|| 论 坛|
  首 页 > 新闻列表 > 行业新闻 > 电生理行业新闻   
新闻分类
新闻搜索
  关键字:
主题 内容 
热门新闻
新闻内容
飞利浦与Biosense Webster在改善不规则心跳的诊断与治疗方面进行合作
【 来源:飞利浦 】 【 发布时间:2008-08-06 】 【 字体:

16 January, 2007
Andover, Mass., and Diamond Bar, Calif., USA – Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Biosense Webster, Inc. announced today that they have signed an agreement to co-develop integrated products that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias. This strategic alliance will enable the creation of an interface that connects Biosense Webster’s Carto™ Mapping and Navigation System with Philips’ integrated Allura Xper electrophysiology (EP) Lab System, as well as with Philips’ Xcelera Cardiovascular Information Solution. The interface between the Carto™ System and Allura Xper Integrated EP Lab can help reduce the amount of time required to setup and perform complex electrophysiology (EP) ablation procedures, which are designed to restore normal heart rhythms. The joint development program will also help by creating easier storage and retrieval of imaging data, allowing physicians to review and report from a single system. “The agreement with Biosense Webster is an important next step for Philips’ dedicated EP business program. We are committed to improving the lab environment, enabling new, more complex procedures, and integrating the EP workflow process across the complete patient care cycle,” said Ronald Tabaksblat, vice president, electrophysiology, for Philips Medical Systems. “Philips’ relationship with Biosense Webster demonstrates our strategy of collaborating with best-in-class companies to develop comprehensive EP product offerings. It promotes our vision of leading the EP market through better, simpler treatment solutions.” “This agreement underscores Biosense Webster’s commitment to empower electrophysiologists and foster health in patients around the world who suffer from irregular heartbeats,” said Roy Tanaka, president, Biosense Webster. “By integrating our systems with Philips’, we will further improve the quality of care that EP labs provide.”
要了解更多信息,请联络:

亚洲: Radhika Choksey
Tel: +91 22 5691 2122
radhika.choksey@philips.com

美国:Steve Kelly, Senior Public Relations Manager
Tel: +1 425-487-7479
E-mail:
steve.kelly@philips.com

Ian Race, Public Relations Manager
Tel: +1 978-659-4624
E-mail: 
ian.race@philips.com

飞利浦简介
荷兰皇家飞利浦电子集团是世界上最大的电子集团之一,在欧洲名列榜首,其2001年的营业额达288亿美元(323亿欧元)。它在彩色电视、照明、电动剃须刀、医疗诊断影像及病人监护仪,以及集成电路电视产品领域世界领先。它拥有166.800 名员工,在60多个国家里活跃在照明、消费电子、家用电器、电子元件、半导体和医疗系统等领域。飞利浦股票已在纽约证券交易所(交易代码:PHG)、伦敦、法兰克福、阿姆斯特丹及其他证券交易所挂牌上市。要查看飞利浦公司的新闻,请访问
www.newscenter.philips.com
 Article options
 Printable version
 Send article
 
+ Return to list of press releases 

添加时间:2008-08-06  浏览次数:751

新闻评论
暂时无数据...
免责声明
新闻免责声明: 本网站的所有资料均为广大电生理爱好者自发收集提供,仅供广大电生理爱好者学习交流之用。资料中如果有侵犯贵公司的商业机密和商业利益,请及时和我们联系,我们将立即删除相关内容。
QQ群:8843682  Email:chs@heartep.com 
版权所有.2006-2009. 心脏电生理爱好者网站  沪ICP备08017164号